View More
Expert faculty explain how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Kenneth Cusi, MD, FACP, FACE
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 26, 2019
Expert hepatologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 29, 2019
Expert endocrinologist explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Kenneth Cusi, MD, FACP, FACE
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.